Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business)

Diagnostic Equipment
Current Valuation
N/A
As of May 1, 2025
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO (Add-on)†

Amount undisclosed

Last Funding
May 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
May 1, 2025Buyout/LBO (Add-on)†UndisclosedN/A-
Valuation Analysis

Current Valuation Metrics

Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business) is currently valued at N/A as of May 1, 2025.

Track Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business) Valuation Updates

Get notified when Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business) raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business)'s valuation history, funding rounds, and growth metrics.

No credit card required

What is Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business) Worth in 2026?

Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business) is a leading private company in the Diagnostic Equipment sector. Track Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business) Valuation is Determined

Private company valuations like Lantheus Medical Imaging (Single Photon Emission Computed Tomography Business)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.